Express Scripts Takes Legal Action Against FTC for Defamation
Tuesday, 17 September 2024, 13:56
Legal Action by Express Scripts
Express Scripts, headquartered in North St. Louis County and a subsidiary of The Cigna Group, has launched a lawsuit against the Federal Trade Commission (FTC). The company is demanding a retraction of a July 2024 report that it claims is defamatory and damaging to its reputation.
The Impact on the Pharmacy Benefit Management Industry
This lawsuit raises significant questions regarding regulations in the pharmacy benefit management sector. The FTC's report has drawn attention to potential issues within the industry, prompting a defensive reaction from Express Scripts.
- Express Scripts seeks to protect its reputation
- The lawsuit could lead to changes in regulatory scrutiny
- Potential implications for the future of pharmacy benefits
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.